So far, there are several models for predicting HCC prognosis, using different gene signatures such as HOXD9, SPP1, SPINK1, TXNRD1 and MAGEB6, and the satisfying performances of those models suggested that these genes could serve as possible drug targets (8, 9). The gene discussed is SPP1; the disease is hepatocellular carcinoma.